Caliper Life Sciences this week reported a decline of 9 percent in its fourth-quarter revenues — in line with its guidance — while taking a $45.3 million charge for goodwill impairment and other restructuring charges.

The Hopkinton, Mass.-based firm brought in revenues of $36.7 million for the three-month period ended Dec. 31, down from revenues of $40.3 million for the fourth quarter of 2007. Caliper said that the organic decline in revenues was 2 percent when excluding the effects of product-line divestitures and foreign currency translation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.